Richard P. Harbottle
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Erythropoietin delivery through kidney organoids engineered with an episomal DNA vector.
Journal: Stem cell research & therapy
Published: December 02, 2024
Generation and functional analysis of melanoma antigen-specific CD8+ T cells derived from S/MAR vector-transfected human induced pluripotent stem cells.
Journal: International journal of cancer
Published: September 03, 2024
Vaccine-induced T cell receptor T cell therapy targeting a glioblastoma stemness antigen.
Journal: Nature communications
Published: July 26, 2024
Feasibility of Direct Vitrectomy-Sparing Subretinal Injection for Gene Delivery in Large Animals.
Journal: Current eye research
Published: April 26, 2024
A Simple Nonviral Method to Generate Human Induced Pluripotent Stem Cells Using SMAR DNA Vectors.
Journal: Genes
Published: March 12, 2024
Novel chimeric antigen receptors for the effective and safe treatment of NY-BR-1 positive breast cancer.
Journal: Clinical and translational medicine
Published: February 29, 2024
Gene Augmentation of CHM Using Non-Viral Episomal Vectors in Models of Choroideremia.
Journal: International journal of molecular sciences
Published: August 18, 2023
Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy.
Journal: Nature biotechnology
Published: June 13, 2023
Successful large gene augmentation of USH2A with non-viral episomal vectors.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 05, 2023
Development of an Orthotopic HPV16-Dependent Base of Tongue Tumor Model in MHC-Humanized Mice.
Journal: Pathogens (Basel, Switzerland)
Published: November 17, 2022
Safe and stable generation of induced pluripotent stem cells using doggybone DNA vectors.
Journal: Molecular therapy. Methods & clinical development
Published: July 23, 2021
Last Updated: 09/26/2026